Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > Analyst Recommendation

<< Previous

Bullboard Posts

Next >>

Comment by biggerbuckson Jul 17, 2017 1:15am

132 Views

Post# 26475105

RE:Analyst Recommendation

I think this may be the little stock that could all goes well neww ceo gets creative we may be 4 - 6$ a share I know thats a stretch but I have seen this before a great sound little company gets new upper management with some great new ambition and we are on the move and its in the wright buisiness as I see it Good luck guys

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading